A Short Overview of Curcuma aeruginosa with Curative Potentials Against COVID-19
| Autor: | Eva Marliana, Emil Bachtiar Moerad, Sjarif Ismail, Swandari Paramita |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
010404 medicinal & biomolecular chemistry
0303 health sciences 03 medical and health sciences 2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) Chemistry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) General Chemistry 01 natural sciences Curcuma aeruginosa 030304 developmental biology 0104 chemical sciences Microbiology |
| Zdroj: | Asian Journal of Chemistry. 33:789-792 |
| ISSN: | 0975-427X 0970-7077 |
| DOI: | 10.14233/ajchem.2021.23060 |
| Popis: | COVID-19 (coronavirus disease) is an infectious disease of the respiratory tract caused by SARS-CoV-2. Nature has provided a great source of antiviral compounds, from which innovative products for the treatment of COVID-19 can be produced. One of the medicinal plants that can be developed for the treatment of COVID-19 is Curcuma aeruginosa Roxb. Previous studies have found tracheospasmolytic and anti-inflammatory activity of this indigenous Curcuma species. There are 10 chemical compounds from Curcuma aeruginosa that have been proven against COVID-19, namely 1,8-cineole (eucalyptol), α-terpineol, β-caryophyllene, β-eudesmol, β-pinene, β-sitosterol, curcumenol, palmitic acid, succinic acid and zingiberene. Further research is needed for C. aeruginosa to become a new antiviral drug for the treatment of COVID-19. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|